The use of octreotide to manage symptoms of bronchorrhea: a case report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 24035070.
- Also identified by DOI 10.1016/j.jpainsymman.2013.06.008 and PMC identifier 4343310.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Octreotide, a synthetic analogue of the hormone somatostatin, is primarily used in palliative medicine because of its antisecretory effect and has been shown to be effective in the management of bowel obstruction, nausea, and diarrhea. Octreotide also has been successfully used for the management of bronchorrhea in both inpatient and outpatient settings. We report the case of a 47-year-old female with a history of bronchioloalveolar cell carcinoma whose copious bronchial secretions were controlled with octreotide. Octreotide should be further evaluated as a first-line treatment for bronchorrhea.
Medical subject headings
- Adenocarcinoma, Bronchiolo-Alveolar
- Antineoplastic Agents, Hormonal
- Bronchial Diseases
- Lung Neoplasms
- Octreotide